Board member and chairman of the board
Read more
Board member and Chairman of the Board since 2016.
Born: 1960
Education and experience: Bachelor of Science in medical microbiology from the University of Manchester and Master of Science in Management and Economics from the University of London, as well as a Fellow from the London Business School Sloan Program. Simon Cartmell has over 40 years of experience in senior executive and board positions in both private and listed companies in the pharmaceutical, biotech, medtech and diagnostic sectors.
Other current roles: Board positions at Oviva AG, Axis Spine Technology Ltd., Route2Advisors Ltd. and Route2Property Ltd.
Holdings in OssDsign: 125 000 shares and 399 521 subscription options.
Simon Cartmell is independent in relation to the Company, the Company management and the Company's major shareholders.
Board member
Read more
Board member since 2024.
Born: 1965
Education and experience: Christer Fåhraeus has thirty years of experience as CEO, board member, and chairman from fast-growing listed and unlisted companies in Life Science and Tech. He is also the founder of companies such as CellaVision AB, FlatFrog Laboratories AB, EQL Pharma AB, Anoto Group AB, Precise Biometrics AB, and Fåhraeus Startup and Growth AB. He has accumulated more than 200 years of combined board experience from listed and unlisted companies.
Medical Candidate and Ph.D. in Neurophysiology from the Faculty of Medicine at Lund University, Master of Science in Medical Engineering from the University of California San Diego (USA), and equivalent to five years of full-time studies in Mathematics and Physics at Lund University and LTH (Engineering Physics). Graduate of the Swedish Armed Forces Interpreter Academy and holds an honorary Doctorate of Technology from Lund University of Technology.
Founder of EQL Pharma AB. Chief Executive Officer 2006 – 2022, thereafter Chairman (2022 -). Board member since 2006. Chairman of the Remuneration Committee.
Other current roles: Chairman of FSG Fund II AB, Fåhraeus Startup & Growth AB, and ApoEco Sverige AB. Board member of Airsonett AB, CellaVision AB, Checkin.com Group AB, FlatFrog Laboratories AB, Melius Pharma AB, and Bionamic AB.
Holdings in OssDsign: -
Christer Fåhraeus is independent in relation to the Company and company management and in relation to the Company's major shareholders.
Board member
Read more
Board member since 2022.
Born: 1966
Education and experience: MBA in Finance and Business Management from Stern School of Business at New York University, BS in Business Administration from Questrom School of Business at Boston University, provides the board with more than 20 years of expertise and experience in the healthcare industry with extensive knowledge in spine, orthobiologics and neuromodulation. Jill has a direct experience in global medical device commercialization, launching innovative technologies, strategic marketing, healthcare consumerism and patient care pathway modeling. During her career, Jill has held leadership roles with major healthcare companies such as Johnson & Johnson and Baxter, as well as serving as an executive at high-growth, innovative companies such as AxoGen (US Nasdaq: AXGN) and ApaTech (UK), a company she helped divest to Baxter and Avation Medical.
Other current roles: CEO and Board Member Avation Medical, Board Member InteloMed, Inc.
Holdings in OssDsign: 85 611 subscription options.
Jill Schiaparelli is independent in relation to the Company and company management and in relation to the Company's major shareholders.
Board member
Read more
Board member since 2019.
Born: 1964
Education and experience: Bachelor of Science in Chemistry from McGill University in 1986 as well as a Master of Business Administration (MBA) from JL Kellogg Graduate School of Management, Northwestern University in 1992. Newton Aguiar has considerable experience of board work and has been a board member of a number of public and private companies, including healthcare companies based in Sweden. He has also been Senior Healthcare Advisor in Warburg Pincus as well as partner and Head of Europe for Avista Capital.
Other current roles: Board member of Intervacc AB and Palette Life Sciences AB.
Holdings in OssDsign: 99 840 shares and 199 760 subscription options.
Newton Aguiar is independent in relation to the Company and company management and in relation to the Company's major shareholders.
Board member
Read more
Board member since 2015.
Born: 1965
Education and experience: MD, PhD, Assoc Prof in Cardiology at Karolinska Institute. Viktor Drvota has over 17 years’ experience from venture capital in life sciences. Drvota was responsible for life science at SEB Venture Capital 2002–2016 and has many years of experience of board duties in biotech and medtech companies.
Other current roles: CEO of Karolinska Development AB. Chairman of the board at Modus Therapeutics AB, Modus Therapeutics Holding AB, Umecrine Cognition AB and KDev Investments AB. Board member at UC Research AB, Dilafor AB and Dilafor Incentive AB. Deputy board member at Promimic AB and Svenska Vaccinfabriken Produktion AB.
Holdings in OssDsign: –
Viktor Drvota is independent in relation to the Company and company management and in relation to the Company's major shareholders.
